Table 3.
Impact of donor types on transplantation outcomes using Cox models weighted on propensity score
| HR | 95% CI | P | |
|---|---|---|---|
| Relapse | |||
| CBT | 1 | – | – |
| UD 10/10 | 0.7 | 0.5–0.8 | <0.001 |
| UD 9/10 | 0.87 | 0.5–0.9 | 0.005 |
| Non relapse mortality | |||
| CBT | 1 | – | – |
| UD 10/10 | 0.6 | 0.5–0.8 | <0.001 |
| UD 9/10 | 0.8 | 0.6–1.1 | 0.1 |
| Leukemia-free survival | |||
| CBT | 1 | – | – |
| UD 10/10 | 0.6 | 0.5–0.8 | <0.001 |
| UD 9/10 | 0.7 | 0.6–0.9 | 0.002 |
| Overall survival | |||
| CBT | 1 | – | – |
| UD 10/10 | 0.6 | 0.5–0.8 | <0.001 |
| UD 9/10 | 0.8 | 0.6–0.9 | 0.004 |
| GVHD-free and relapse-free survival | |||
| CBT | 1 | – | – |
| UD 10/10 | 0.7 | 0.6–0.9 | <0.001 |
| UD 9/10 | 0.8 | 0.6–0.9 | 0.008 |